For investors in gene therapy biotech bluebird bio, a wait-and-see approach toward a proposed acquisition has paid off. | For ...

Kyndryl ( Nasdaq:KD) and Microsoft ( Nasdaq:MSFT) broadened their existing partnership to bring together Microsoft’s adaptive ...

We recently published an article titled Billionaire David Einhorn’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Kyndryl Holdings, Inc. (NYSE ...

NYSE-listed provider of mission-critical enterprise technology services Kyndryl has launched its new innovation lab in Liverpool, which aims to create up to 1,000 jobs in three years. The Kyndryl AI ...

Rewey Asset Management, an investment management company, released its Q4 2024 investor letter. Here is what the fund said: “Kyndryl Holdings, Inc. (NYSE:KD), which we highlighted in our 3Q24 ...

Kyndryl, a provider of mission-critical enterprise technology services, has announced the opening of its new Kyndryl AI Innovation Lab Liverpool at the iconic Royal Liver Building. The new office ...

Kyndryl CEO Martin Schroeter also spoke about the company's path back to growth. Judge rules Trump unlawfully invoked Alien Enemies Act against alleged Tren de Aragua members Dave Ramsey bluntly ...

I am excited about Lancaster’s clergy and residents visiting Lancaster Nursing and Rehabilitation Center (formerly Conestoga View) on Friday from 11 a.m. until 1 pm. According to the U.S. Census ...

The most recent trading session ended with Kyndryl Holdings, Inc. (KD) standing at $32.42, reflecting a -0.67% shift from the previouse trading day's closing. This change lagged the S&P 500's ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Kyndryl Holdings, Inc. (NYSE: KD) resulting from ...

Kyndryl Holdings, Inc. (KD) closed at $32.04 in the latest trading session, marking a -0.03% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.06% for the ...

NEW YORK, April 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD). Such investors are ...